Advertisement

Topics

Canadian Society of Clinical Chemists (CSCC) Company Profile

15:00 EST 13th December 2018 | BioPortfolio

The Canadian Society of Clinical Chemists (CSCC) is a national scientific and professional society representing clinical biochemists across Canada. It provides leadership in the practice of clinical biochemistry and clinical laboratory medicine through service, education and research. The Society establishes standards for diagnostic services and serves as a resource to goverment, industry and healthcare associations, in the interest of the general public

Location

P.O. Box 1570, 4 Cataraqui Street, Suite 310
Kingston
Ontario
K7L 5C8
Canada

Contact

Phone: 613-531-8899
Fax: 613-531-0626
Email: office@cscc.ca


News Articles [1657 Associated News Articles listed on BioPortfolio]

Immunotherapy Approval Offers New Hope in CSCC

Treatment for cutaneous squamous cell carcinoma (CSCC) took a great leap forward in September 2018 with the PD-1 inhibitor cemiplimab becoming the first agent specifically approved by the FDA for adva...

FDA Approves Cemiplimab, First Drug for Advanced CSCC

The US Food and Drug Administration today approved cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced, unresectable CSCC. FDA Appro...

FDA Approves Cemiplimab for CSCC

The FDA has approved the PD-1 inhibitor cemiplimab (Libtayo) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC who are not c...

FDA approves first treatment for advanced form of the second most common skin cancer

FDA approves Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or cu...

Clinical trials needed to study cannabinoid use in Canadian children

(Canadian Medical Association Journal) Canadian parents use unregulated cannabinoids for seizure control in children with neurologic conditions like epilepsy, and clinical trials are needed to inform ...

Castle Biosciences’ Cutaneous Squamous Cell Carcinoma Prognostic Test Development Progress Highlighted in Oral Presentation at American Society for Dermatologic Surgery Annual Meeting

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data demo...

Chemists find a surprisingly simple reaction to make a family of bioactive molecules

Many natural products and drugs feature a so-called dicarbonyl motif -- in certain cases however their preparation poses a challange to organic chemists. In their most recent work, chemists present a ...

FDA Approves First Treatment for Advanced Cutaneous Squamous Cell Carcinoma

Officials with the FDA have approved cemiplimab-rwlc (Libtayo) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates fo...

PubMed Articles [4365 Associated PubMed Articles listed on BioPortfolio]

Canadian Anesthesia Incident Reporting System (CAIRS): The Canadian Anesthesiologists' Society's National Patient Safety Initiative.

Genetic variants in the HLA class II region associated with risk of cutaneous squamous cell carcinoma.

The immune system has been implicated in the pathophysiology of cutaneous squamous cell carcinoma (cSCC) as evidenced by the substantially increased risk of cSCC in immunosuppressed individuals. Assoc...

Incidence, demographics and surgical outcomes of cutaneous squamous cell carcinoma diagnosed in Northland, New Zealand.

Non-melanoma skin cancer (NMSC) is the most commonly diagnosed and most costly cancer in Australasia. Cutaneous squamous cell carcinoma (cSCC) accounts for approximately 25% of NMSC. Despite this, rep...

2018 Canadian Spine Society Abstracts.

Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.

Cutaneous squamous cell carcinoma (CSCC), an epidermal keratinocyte-derived skin tumor, is one of the most leading causes of cancer-associated morbidity and mortality worldwide. Long noncoding RNAs ha...

Clinical Trials [2483 Associated Clinical Trials listed on BioPortfolio]

Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)

This is a prospective study which aims to explore the effect of Trimetazidine on the improvement of coronary microvascular dysfunction in patients with INOCA (ischemia and no obstructive c...

Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

To estimate the clinical benefit of REGN2810 monotherapy for patients with metastatic (nodal or distant) cutaneous squamous cell carcinoma (CSCC) (Group 1) or with unresectable locally adv...

Study of Pembrolizumab (MK-3475) in Adults With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) (MK-3475-629/KEYNOTE-629)

The purpose of this study is to evaluate the safety and efficacy of pembrolizumab (MK-3475) in adult participants with recurrent or metastatic cutaneous Squamous Cell Carcinoma (R/M cSCC) ...

Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study

Localized cutaneous squamous cell carcinoma (CSCC) is usually treated by radical surgery with or without radiotherapy. The cure rate is high around 90% of cases (1). Unresectable CSCC repr...

Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance

Cutaneous Squamous Cell Cancer (Cscc, 25%) and basal cell carcinoma (BCC; 75%) are the major subtypes of non-melanoma skin cancer. Most cSCC arise in the head and neck region because it is...

Companies [2438 Associated Companies listed on BioPortfolio]

Canadian Society of Clinical Chemists (CSCC)

The Canadian Society of Clinical Chemists (CSCC) is a national scientific and professional society representing clinical biochemists across Canada. It provides leadership in the practice of clinical b...

Swiss Chemical Society (SCS)

In 1992 the New Swiss Chemical Society was founded by a merger of the Swiss Chemical Society (founded 1901) and the Association of Swiss Chemists (founded 1920). As a result these predecessor societie...

Canada Cares

Canada Cares is a not-for-profit organization dedicated to raising awareness about caregiving and providing support for family and professional caregivers. It was founded through ...

International Federation of Clinical Chemistry and Laboratory Medicine

IFCC achieves its goals by publishing information and guidelines relating to the education of clinical chemists, by defining principles and publishing recommendations for the standardisation of analyt...

Canadian Cancer Society (Alberta NWT Division)

More Information about "Canadian Society of Clinical Chemists (CSCC)" on BioPortfolio

We have published hundreds of Canadian Society of Clinical Chemists (CSCC) news stories on BioPortfolio along with dozens of Canadian Society of Clinical Chemists (CSCC) Clinical Trials and PubMed Articles about Canadian Society of Clinical Chemists (CSCC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Canadian Society of Clinical Chemists (CSCC) Companies in our database. You can also find out about relevant Canadian Society of Clinical Chemists (CSCC) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record